PSA-PH Financial Statements & Analysis
Complete financial statements for PSA-PH including income statement, balance sheet, and cash flow statement. Analyze PSA-PH's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
2.7% ↑
Net Income
-13.9% ↓
Gross Margin
-65.9% ↓
Operating Margin
-0.3% ↓
Balance Sheet
Current Ratio
-1.3% ↓
Debt to Equity
15.1% ↓
Asset Turnover
0.4% ↑
Cash Flow
Operating Cash Flow
1.9% ↑
Net Cash Flow
-374.9% ↓
Free Cash Flow
7.0% ↑
Cash Flow to Debt
-7.1% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 4.70B | 4.82B | 2.7% | |
| Gross Profit | 3.44B | 1.20B | 65.0% | |
| Operating Income | 2.20B | 2.25B | 2.4% | |
| Net Income | 2.07B | 1.78B | 13.9% | |
| EPS | 10.68 | 9.04 | 15.4% | |
| EBITDA | 3.51B | 3.25B | 7.4% | |
| Gross Margin | 73.21% | 24.96% | 65.9% | |
| Operating Margin | 46.88% | 46.73% | 0.3% | |
| Net Income Margin | 44.13% | 36.99% | 16.2% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.82B | 4.70B | 4.52B | — | — |
| Gross Profit | 1.20B | 3.44B | 3.37B | — | — |
| Operating Income | 2.25B | 2.20B | 2.32B | — | — |
| Net Income | 1.78B | 2.07B | 2.15B | — | — |
| EPS | 9.04 | 10.68 | 11.11 | — | — |
| EBITDA | 3.25B | 3.51B | 3.34B | — | — |
| Gross Margin | 24.96% | 73.21% | 74.59% | — | — |
| Operating Margin | 46.73% | 46.88% | 51.33% | — | — |
| Net Income Margin | 36.99% | 44.13% | 47.55% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into PSA-PH's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics